Your A1C Is Climbing And Your Doctor Just Said "Try Harder." There's A Better Move.
The Honest Version.
You're not lazy. You're not weak. You have a metabolic condition in a body that was designed for famine.
If your A1C keeps climbing but you're being told to try harder, the problem may not be your willpower. It may be your biology.
Semaglutide is one of the most studied medications for fixing exactly that. It mimics a gut hormone called GLP-1, lowers A1C by 1.4 to 1.8 points on average in adults with type 2 diabetes,¹ and usually brings weight down as well.
The first month can be rough. But for the right person, it does in months what diet and walking alone struggle to do in years.
Your gut makes a hormone called GLP-1 whenever you eat. GLP-1 is a little chemical postman. It runs around your body delivering three notes.
One note goes to your pancreas and says, insulin, wake up. One note goes to your liver and says, please stop dumping sugar into the bloodstream, we have plenty. And one note goes to your brain and says, we are full now, you can stop thinking about the leftover pizza.
In type 2 diabetes, the postman gets slow. The notes still go out, but late, and a little smudged. The pancreas reads them wrong. The liver does its own thing. The brain keeps thinking about the pizza.
Semaglutide is, basically, a much more reliable postman. Same notes. Better delivery. And, crucially, it stays on the route for about a week instead of about ten minutes.
An A1C of 8.5 is a person whose doctor is worried. An A1C of 6.7 is a person whose doctor smiles.
In the clinical trials, which were called SUSTAIN, because someone in a meeting once decided we name drug trials like superhero franchises, adults with type 2 diabetes lowered their A1C by 1.4 to 1.8 percentage points.²
Which sounds small. It is not small. The space between 8.5 and 6.7 is the entire emotional content of a follow-up appointment.
People also lost weight. Nine to fourteen pounds, on average, without doing anything heroic. The weight loss is not the point of the medication, technically, but it helps. Being a little lighter means your cells listen to insulin a little better, which means your blood sugar drops a little more. It's a nice little circle of good news in a category of life that does not usually offer those.
Semaglutide for diabetes is approved for adults with type 2. If that's you, you're in the conversation. It's usually offered when:
Metformin is doing its honest best and your A1C is still north of where you and your doctor want it.
You also need to lose some weight, you have tried, and the trying has not gotten you there. Which, again, is not a moral failing. It's biology.
You'd like a once-a-week shot rather than a daily pile of pills. Or vice versa, depending on which kind of person you are.
You have a heart, and you'd like to keep it. In patients with type 2 diabetes and established cardiovascular disease (or high risk for it), semaglutide has been shown to reduce major adverse cardiac events.³ The kind of bonus you don't get from cutting out crackers.
Semaglutide is not for type 1 diabetes. A personal or family history of medullary thyroid carcinoma or MEN2 also rules it out. A real conversation with a licensed provider — covering your full medical history, current medications, and labs — is the only safe way to determine whether semaglutide is right for you.
In the first month, you'll probably feel some nausea. A slow, mild queasiness that comes and goes. It particularly happens after meals that have too much grease in them — the body's gentle way of saying, hey, remember those nachos? We're reconsidering the nachos.
Some people feel reflux. Some people feel, for the first time in their adult life, that they forgot to eat lunch. Which is disorienting, because lunch is supposed to be a major event, and now it is not, and you have to find new things to look forward to.
This passes for most people by week four or five. The medication is supposed to be titrated up slowly — starting at a very small dose and climbing gently over months. Providers who skip the slow climb to get you to weight-loss results faster are doing you a small wrong. The slow climb is the whole game.
Rarely, more serious things happen. Pancreatitis. Gallbladder trouble. If you get a sharp pain in your belly that doesn't pass, you call your provider. You do not Google it for two hours first. You do not ask Reddit. You call.
The needle is tiny. People who've been terrified of needles since they were six usually look down after the first one and say, oh, that was it?
Tends to lower A1C a little more, because the body absorbs it more reliably.
It's real, it works, but it is fussy. Morning, empty stomach, small sip of water, nothing else for 30 minutes.
If you wake up and immediately need coffee to be a human being, Rybelsus is going to be hard on you.
Both are fine. Both are real medicine.
Brand-name semaglutide is expensive without insurance. This is not a secret. If you have type 2 diabetes, your insurance will usually cover Ozempic or Rybelsus, sometimes after a little paperwork dance called prior authorization, which is the insurance company's way of making sure you really meant it.
If insurance doesn't come through, talk to your provider about your options. There are manufacturer savings programs, patient assistance programs, and other GLP-1 medications that may be covered differently under your plan. A good clinic will walk you through what's actually available to you.
A note on compounded GLP-1s: compounded semaglutide is not FDA-approved, and the FDA has issued warnings about safety and quality concerns with some compounded versions.⁴ Any decision about compounded medication should happen in a clinical conversation with a licensed provider, not based on a marketing page.
Here's the part where I'll be straight with you, because you've been lied to enough.
For most people with type 2 diabetes, this is a long-term medication. Not forever, necessarily, but long-term. The way a blood pressure medication is long-term. You take it because your body, on its own, is not regulating the thing it's supposed to regulate. The medication does the regulating. If you stop the medication, the thing it was regulating stops being regulated.
Some people, through real weight loss, real strength training, real changes that stack up over years, get to a place where they can taper off. That's a real outcome. It's not the default outcome. Plan, in your head, for a long relationship with this medication. If you get to leave it earlier, that's a bonus.
You are not lazy.
You are not weak.
You did not bring this on yourself by enjoying a sandwich.
You have a metabolic condition, in a body that was designed for famine and is now operating in a world of abundance. The design did not anticipate the abundance. The abundance has consequences. One of those consequences is a number on a lab report that has been creeping up while you have been trying, in good faith, to bring it down.
Semaglutide is not magic. It is not a personality. It is a well-studied, well-understood medication that does, for a lot of people, exactly what diet and walking and the little blue book were never quite going to do alone.
It's worth a real conversation with someone who treats your diabetes as a medical condition — which it is — and not as a character flaw, which it never was.
You've done enough trying harder.
You're allowed to try differently.
Because That's What It Is.
Limitless Alternative Medicine has licensed providers who treat type 2 diabetes with appropriate medication, ongoing monitoring, and a real human being on the other end of the visit. Telehealth appointments often available within days.
Book A Consultation →- Marso, S. P., et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine, 375(19), 1834–1844. View study
- U.S. Food and Drug Administration. Ozempic (semaglutide) injection — Prescribing Information. View FDA label
- American Diabetes Association. Standards of Care in Diabetes — Pharmacologic Approaches to Glycemic Treatment. View guidelines
- U.S. Food and Drug Administration. Medications Containing Semaglutide — Safety Communication. View advisory
This article is for general educational purposes only and is not medical advice, diagnosis, or treatment. Semaglutide (Ozempic, Rybelsus, Wegovy) is a prescription medication with serious potential side effects and contraindications. Talk to a licensed healthcare provider before starting, stopping, or changing any treatment. Individual results, risks, and side effects vary. The information here does not replace the clinical judgment of a qualified healthcare professional who has reviewed your personal medical history, current medications, and lab values. If you experience severe abdominal pain, signs of an allergic reaction, vision changes, or any other concerning symptoms, contact your provider or seek emergency care immediately.